HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

3',4'- dihydroxy- 5,6,7,8- tetramethoxyflavone

structure in first source

Networked: 1 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyrans: 130
    - Benzopyrans: 195
      - Chromones: 159
        Flavonoids: 9773
        Flavones: 446
        3',4'-dihydroxy-5,6,7,8-tetramethoxyflavone: 1
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Benzopyrans: 195
      - Chromones: 159
        Flavonoids: 9773
        Flavones: 446
        3',4'-dihydroxy-5,6,7,8-tetramethoxyflavone: 1

Experts

1.	Ho, Chi-Tang: 1 article (02/2010)
2.	Kou, Mei-Chun: 1 article (02/2010)
3.	Li, Shiming: 1 article (02/2010)
4.	Lo, Ya-Hsuan: 1 article (02/2010)
5.	Pan, Min-Hsiung: 1 article (02/2010)
6.	Wu, Ming-Jiuan: 1 article (02/2010)
7.	Yen, Jui-Hung: 1 article (02/2010)

Related Diseases

1.	Atherosclerosis 02/01/2010 - "Current study focused on the effect and mechanism of 3',4'-dihydroxy-5,6,7,8-tetramethoxyflavone (DTF), a major metabolite of nobiletin (NOB, a citrus polymethoxylated flavone) on atherogenesis. "

Related Drugs and Biologics

1.	flavone
2.	nobiletin